Clinical Trials Directory

Trials / Conditions / Carcinoma of the Appendix

Carcinoma of the Appendix

14 registered clinical trials studyying Carcinoma of the Appendix.

StatusTrialSponsorPhase
WithdrawnDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
NCT04985357
Travera Inc—
CompletedMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
NCT05461430
Travera Inc—
CompletedQuality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
NCT01126346
Wake Forest University Health SciencesN/A
TerminatedPalonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Prim
NCT00903396
Alliance for Clinical Trials in OncologyPhase 2
CompletedSurgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
NCT01580410
Wake Forest University Health SciencesPhase 2
CompletedIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
NCT00654160
Mayo ClinicPhase 1
CompletedIntraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer D
NCT00458809
Wake Forest University Health SciencesPhase 1
CompletedErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Nec
NCT00397384
National Cancer Institute (NCI)Phase 1
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
CompletedThalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throug
NCT00310076
Wake Forest University Health SciencesPhase 2
Completed7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid
NCT00031681
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1
CompletedOxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer
NCT00019773
National Cancer Institute (NCI)Phase 1
UnknownFluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
NCT00006112
Gustave Roussy, Cancer Campus, Grand ParisPhase 2